Iulian Bobe
Publications by Year
Research Areas
Nanoparticle-Based Drug Delivery, Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research, Pancreatic and Hepatic Oncology Research, Radiopharmaceutical Chemistry and Applications
Most-Cited Works
- → Nanomedicines: From Bench to Bedside and Beyond(2016)147 cited
- → Phase Ib/II Trial of NC-6004 (Nanoparticle Cisplatin) Plus Gemcitabine in Patients with Advanced Solid Tumors(2017)108 cited
- → Improved anti‐tumor activity of stabilized anthracycline polymeric micelle formulation, NC‐6300(2010)97 cited
- → A Phase 1b Dose Escalation Trial of NC-6300 (Nanoparticle Epirubicin) in Patients with Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft-tissue Sarcoma(2020)35 cited
- → A multicenter, single-arm, basket design, phase II study of NC-6004 plus gemcitabine in patients with advanced unresectable lung, biliary tract, or bladder cancer(2020)29 cited
- → Physico-chemical characterization of polymeric micelles loaded with platinum derivatives by capillary electrophoresis and related methods(2014)23 cited
- → Phase Ib/II trial of NC-6004 (nanoparticle cisplatin) plus gemcitabine (G) in patients (pts) with advanced solid tumors(2016)3 cited
- → Phase Ib/II trial of NC-6004 (nanoparticle cisplatin) plus gemcitabine (G) in pts with advanced solid tumors(2016)2 cited
- → P1.03-044 Exploratory Analysis of Lung Cancer Patients in a Phase Ib/II Trial of NC-6004 (Nanoparticle Cisplatin) plus Gemcitabine(2017)1 cited
- → Figure S2 from A Phase 1b Dose Escalation Trial of NC-6300 (Nanoparticle Epirubicin) in Patients with Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft-tissue Sarcoma(2023)